Abstract
For 5% of the global population, disabling age-related and noise-induced hearing loss (SNHL) is associated with isolation, depression, cognitive decline, and dementia. On an economic level, SNHL is correlated with decreased employment, particularly for manual labor. Here we present one of the largest genome-wide association studies (GWAS) on SNHL to date, using clinical diagnosis from the Million Veteran Program (MVP) (210,240 cases and 265,275 controls). GWAS findings are contrasted and then meta-analyzed with the United Kingdom Biobank (UKB) self-reported hearing loss GWAS (87,056 cases and 163,333 controls). We identify substantial genetic overlap despite differences in demographics, experiences, and source of phenotypes. Meta-analysis of the two cohorts identifies 108 loci, including novel and known familial hearing loss genes. Significant gene ontology pathways included “sensory perception of mechanical stimulus,” “ear development,” “actin-binding,” and “cytoskeletal protein binding,” indicative of mechanosensory structure and function in the cochlea. Eighteen congenital hearing loss genes are suggested, expressing proteins in subcellular regions of inner and outer hair cells, including stereocilia, rootlets, and mechanoelectrical transduction tip-links, as well as supporting cells, Type 1 neurons and stria vascularis. SNP-based heritability estimates over familial hearing loss genes showed a 3.26 fold enrichment relative to genes not listed as familial hearing loss genes. However, due to the small number of familial hearing loss genes, the majority of heritability was accounted for by genes not yet designated as hearing loss genes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research is based on data from the Million Veteran Program, Office of Research and Development, Veterans Health Administration, and was supported by MVP_000, MVP_060 and MVP_039 as well as award #IO1RX004293.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Central Institutional Review Board of the Department of Veterans Affairs qualified MVP_039 and MVP_060 for exemption under category 4(ii).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos